Amaç: Prokalsitonin enfeksiyon markırı olarak bilinir. Malondialdehid oksidatif stres markırı kabul edilir. Periton diyaliz hastalarında iki markır da yüksek olarak tesbit edilmiştir. Bu çalışmada prokalsitonin, malondialdehid, C reaktif protein, albümin, fıbrinojen, lokosit, lenfosit ve sedimentasyon gibi inflamasyon markırları hemodiyaliz hastalarında, orta derecede böbrek yetersizliği olan hasta grubunda ve sağlıklı kontrol grubunda belirlendi. Gereç ve Yön- 
Introduction
Chronic kidney disease (CKD) is global health problem affecting about 10% of the world population [1] . The condition is related to high mortality, morbidity, health care resource use, and costs [3] [4] . In patients with chronic kidney disease, the most common cause of death is cardiovascular diseases and followed by infections [5] [6] [7] . Therefore, it is important to establish reliable markers of bacterial infections to optimize management of infections in the CKD patient population. The prevalence of malnutrition, inflammation, and atherosclerosis-also called MIA syndrome--is high in patients with CKD and signifies oxidative stress and cardiovascular risk [2, 3] . In addition to traditional cardiovascular risk factors, non-traditional cardiovascular risk factors also need to be addressed in the management of CKD patients to improve quality and quantity of life [8, 9] . Indicators of disease activity in CKD patients have been an area of interest for many researchers. Classical markers of infections and inflammation include albumin, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell counts (WBC). CRP is a cytokine mediated acute phase reactant. The marker guides clinicians to follow disease activity and prognosis [10] . However, CRP has not proven to be significant for mortality in hemodialysis (HD) patients [11] . Procalcitonin (PCT) is a precursor of calcitonin which is secreted by the thyroid C cells, also called parafollicular cells [7, [12] [13] [14] . PCT is secreted by the liver in bacterial infections and exceed the normal limit of 0.1 ng/ml in the normal population [9, [12] [13] [14] . Malondialdehyde is a marker of oxidative stress and has been shown to be elevated in dialysis patients [8, 15] . Our objective was to assess serum levels of MDA (a marker of oxidative stress) and of PCT (a marker of bacterial infections and systematic inflammation) in patients who were on HD three times per week (group A); in patients with an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m2 (group B); and in healthy subjects with GFR of more than 90 ml/min/1.73 m2 (group C). We measured the difference in PCT, MDA, albumin, CRP, ESR, fibrinogen, lymphocyte counts, and WBC between the groups. We also explored the correlation between PCT and MDA with albumin, CRP, ESR, fibrinogen, lymphocyte counts, and WBC.
Material and Method Patients
This study was based on the nephrology thesis of Dr. Nigar Sekercioglu. This is a cross-sectional study of sixty-five adult patients with stages 4 through 5D CKD and twenty healthy controls. HD patients were recruited from the University of Istanbul Cerrahpasa Faculty of Medicine Hospital Hemodialysis Unit. Patients with CKD were recruited from the University of Istanbul Cerrahpasa Faculty of Medicine Hospital outpatient nephrology clinics. ) using a specific calculator designed for eGFR estimation with the MDRD equation [16] . Inclusion criteria included (1) being an adult patient (18 years), (2) being on HD for three times per week for the group A, (3) having some degree of kidney dysfunction with a GFR cut-off level of 60 L/min/1.73m2 for group B, and (4) agreeing to participate in the study. Exclusion criteria included those with: (1) tuberculosis, (2) known bacterial infections, (3) diabetes mellitus, (4) active vasculitis, or (5) inflammatory bowel diseases (Crohn's or ulcerative colitis). This study was approved by the University of Istanbul Cerrahpasa Faculty of Medicine Research Ethics Authority. An informed consent was obtained from each participant. One fasting blood sample was collected from all participants and sent to the Central Research Laboratory for analysis. The blood samples were centrifuged and stored at -60 C0 and were analyzed immediately after being thawed. In HD patients, we collected blood samples before starting dialysis. Samples were collected on Monday from patients on a Monday-WednesdayFriday schedule and on Tuesday from those on a TuesdayThursday-Saturday schedule. PCT was measured using DiaSorin assay (DiaSorin, Saluggia, Italy). The normal cut-off value for PCT was <0.5ng/ml. MDA was measured using the technique suggested by Buege and August with thiobarbituric acid reactive substances [17] . Albumin was measured using the Olympus AU 800 Analyzer (Olympus, Japan). CRP was measured using a high sensitivity immunonephelometric technique (Dade Behring, Marburg, Germany). In healthy subjects, the normal limits of CRP range from 0 to 5 mg/L. Fibrinogen was measured using a Dade Behring Dimension Analyzer (Dade Behring, Germany). ESR was measured using an Eriline AR Linear (Barcelona, Spain) device. Albumin was measured using an Olympus AU 800® Analyzer (Japan). WBC and lymphocyte counts were measured using an HmX Hematology Analyzer (Beckman Coulter, USA).
Statistical analysis
The analysis plan included descriptive and inferential statistics. Counts and percents were used to summarize categorical variables, while means and standard deviations (SD) were used for continuous variables. We employed the Pearson's Chi Square test to examine the distribution of patients' characteristics for categorical variables. We employed two-sample t tests to compare mean differences between the groups for continuous variables. MDA and PCT were tested for association with various covariates using the Spearman's coefficient of correlation (r in the tables). Two-sided tests were employed with a significance level of 0.05. All data analyses were performed using IBM SPSS Statistics 20, Release Version 10.0 (SPSS Inc., Chicago, IL; www. spss.com).
Results
Our study cohort consisted of eighty-five subjects. In this cohort, the most common cause of end stage renal disease was chronic glomerulonephritis, and hypertension was the most common cause of underlying CKD in non-dialysis CKD patients. Healthy controls, patients with moderate chronic kidney disease and HD patients had mean eGFR of 111 (SD=11.3), 39.9 (SD=9.9), and 9.8 (SD=16) ml/min/1.73m2, respectively. The group A consisted of 35 HD patients (25 males and 10 females). The mean age of these patients was 47.5 years (SD= 15.3) ( Table 1) . Of these 35 patients, 18 had chronic glomerulonephritis, seven had hypertension, five had polycystic kidney disease, four had unknown etiology, and one patient had rapidly progressive glomerulonephritis (Table 1) . The mean dialysis vintage was 21.9 months (SD=12.6). We included 30 patients in the group B (18 males and 10 females). The mean age in the group B was 49 years (SD=18.6). A total of 17 patients had hypertension in the group B. Five patients had membranous glomerulonephritis while 4 patients had membranoproliferative glomerulonephritis. The mean eGFR of non-dialysis CKD patients was 39.9 ml/min/1.73m2. We included 20 healthy subjects in the group C (14 males and 8 females), for which the mean age was 41.2 years. GFR was above 90/ml/min/1.73m2 (mean was 111 ml/min/1.73 m2) in the group C. MDA was significantly higher in the group A as compared to the group B and group C. Also, MDA was significantly higher in the group B as compared to the group C ( Table 2) . PCT was significantly higher in the HD patients than patients in groups B and C. However, the difference in PCT did not reach a statistically significant level between groups B and C. Fibrinogen, WBC, and CRP did not indicate significantly different results between the groups. Lymphocyte count was significantly lower in groups A and B when compared to the group C. Nevertheless, there was no significant difference in lymphocyte count between groups A and B. Albumin was significantly lower in HD patients as compared to healthy controls. However, the difference for albumin was not significant between groups B and C. ESR was significantly higher in HD patients as compared to groups B and C. However, there was no significant difference in ESR between groups B and C (Table 2 ).
In the group A, only CRP was positively correlated with PCT (r=0.89, p=0.0001) ( Table 3 ). In the group B, fibrinogen and creatinine were positively correlated with PCT (r=0.36, p=0.04 for fibrinogen and r=0.38, p=0.03 for creatinine) (Table 4 ). In the group C, BUN was negatively correlated with PCT (r=-049, p=0.02) ( Table 5 ). Other covariates did not reach a significant level (Table 5 ). In the group A, none of the variables indicated significant correlation with MDA (Table 3 ). In the group B, none of the variables indicated significant correlation with MDA (Table 4 ). In the group C, CRP and ESR were positively correlated with MDA (r=0.75, p=0.0001 for CRP and r=0.49, p=0.02 for ESR). Other covariates did not reach a significant level (Table 5 ).
Discussion
Our aim was to explore the difference in PCT, MDA, albumin, CRP, ESR, fibrinogen, lymphocyte counts, and WBC between pa- tients with different levels of kidney dysfunction and healthy controls. We also explored the correlation between PCT and MDA with other inflammation markers. HD patients showed significantly higher PCT, MDA, and ESR levels as compared to non-dialysis CKD patients and healthy controls. Fibrinogen, WBC, and CRP did not indicate significantly different results between the groups, while albumin was significantly lower in HD patients as compared to healthy controls. With regards to correlations between the markers, CRP was positively correlated with PCT in HD patients. Our results indicated that PCT was significantly higher in HD patients. Nevertheless, PCT was not significantly higher in non-dialysis CKD patients as compared to healthy controls in our study. Results from previous reports support our findings. Visardis et al. investigated the correlation between PCT and traditional inflammation markers. Results indicated that 38% of HD patients had elevated PCT levels [18] . Herge et al. found a negative correlation between GFR and PCT level. The authors attributed the elevated levels to increased synthesis of PCT from peripheral blood mononuclear cells and reduced clearance of PCT by the kidneys [19] . Opatrna et al. showed that PCT was significantly higher in peritoneal dialysis (PD) patients as compared to healthy controls [20] . In line with these findings, another study showed normal levels of PCT in HD patients and elevated levels of PCT in PD patients without bacterial infection [7] . However, Sitter et al. failed to show a significant correlation between PCT and eGFR [21] . Thus, the authors concluded that PCT as a marker of infection had acceptable diagnostic properties (sensitivity and specificity) for systematic bacterial infections in CKD patients [21] . In our study, the correlation of CRP with PCT was significant (p=0.0001) with a coefficient of r=0.89. This is supported by previous reports. CRP was positively correlated with PCT in HD patients (r=0.50) [20] and PD patients (r=0.59) [21] . Since CKD patients show elevated CRP levels, the marker has been associated with more false positive results in CKD patients [18, 21] . CRP has been found to be relatively stable after dialysis. Dahaba et al. found significantly lower PCT values after dialysis while CRP levels remained the same [22] . Nondialyzable inflammation markers are useful tools for dialysis patients. However, it is important to connect these surrogate markers to patientimportant outcomes, such as mortality. Owen et al. failed to show a significant relationship between CRP and mortality [11] .
Our results showed lower levels of serum albumin in HD patients as compared to non-dialysis CKD patients and health controls. Tombul et al. studied 60 dialysis patients (30 HD and 30 PD) to test the difference in inflammation markers (albumin, CRP, ESR and fibrinogen). The results indicated that albumin was lower in PD patients [23] .
MDA was significantly higher in HD patients and non-dialysis CKD patients as compared to healthy controls. This is congruent with previous reports. Miller et al. reported that MDA was elevated in dialysis patients [24] . Furthermore, a study investigated the differences in ESR, CRP, and MDA in patients with CKD and health controls [25] . Those with CKD had elevated serum levels of CRP and MDA [25] . Ours was a cross-sectional study of CKD patients and health controls. We pre-defined our research question and objectives. We employed statistical methods to explore: (1) the differences between the groups, and (2) the correlation between inflammation markers using the frequentist approach. However, there are several limitations that need to be addressed. First, this is a cross-sectional study and may be used only for hypothesisgenerating. Secondly, we did not include PD patients and kidney transplant recepients. Thus, results may not be applicable for patients who were on different renal replacement therapies. Overall, we reported that dialysis and non-dialysis CKD patients showed elevated PCT and MDA levels. Albumin was lower in dialysis patients as compared to healthy controls. Our findings support the presence of chronic inflammation in CKD patients. The remaining important question is the relationship of these markers with important patient outcomes, such as renal and patient survival. 
